| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP &Chief Medical Officer
1 company
Smith Jeffrey T L is an EVP &Chief Medical Officer at Zymeworks Inc.. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $885K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | ZYME Zymeworks Inc. | EVP &Chief Medical Officer | Sale+OE | 9,310 | $22.67 | $211,090.29 | -25.8% | +13.6% | - | |
| Jan 5, 2026 | ZYME Zymeworks Inc. | EVP &Chief Medical Officer | Sale+OE | 10,538 | $25.10 | $264,471.13 | -36.5% | +1.4% | - | |
| Jan 6, 2025 | ZYME Zymeworks Inc. | EVP &Chief Medical Officer | Sale+OE | 11,110 | $14.92 | $165,806.75 | -55.5% | -27.9% | +67.2% |